Related Experiment Video
Updated: Jul 9, 2026

Examining BCL-2 Family Function with Large Unilamellar Vesicles
Published on: October 5, 2012
BCL-2 family proteins: critical checkpoints of apoptotic cell death
1Department of Pathology, Harvard Medical School and Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02115, USA. nika_danial@dfci.harvard.edu
Abstract:
Apoptosis is a morphologically distinct form of programmed cell death essential for normal development and tissue homeostasis. Aberrant regulation of this pathway is linked to multiple human diseases, including cancer, autoimmunity, neurodegenerative disorders, and diabetes. The BCL-2 family of proteins constitutes a critical control point in apoptosis residing immediately upstream of irreversible cellular damage, where family members control the release of apoptogenic factors from mitochondria. The cardinal member of this family, BCL-2, was originally discovered as the defining oncogene in follicular lymphomas, located at one reciprocal breakpoint of the t(14;18) (q32;q21) chromosomal translocation. Since this original discovery, remarkable efforts marshaled by many investigators around the world have advanced our knowledge of the basic biology, molecular mechanisms, and therapeutic targets in the apoptotic pathway. This review highlights findings from many laboratories that have helped uncover some of the critical control points in apoptosis. The emerging picture is that of an intricate cellular machinery orchestrated by tightly regulated molecular interactions and conformational changes within BCL-2 family proteins that ultimately govern the cellular commitment to apoptotic death.
Insights
Programmed cell death, or apoptosis, is vital for health and disease. The BCL-2 protein family critically regulates this process, impacting diseases like cancer and neurodegeneration.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Apoptosis is programmed cell death crucial for development and homeostasis.
- Dysregulation of apoptosis is implicated in diseases such as cancer, autoimmunity, and neurodegeneration.
- The BCL-2 protein family acts as a key regulator of apoptosis, controlling mitochondrial pathways.
Purpose of the Study:
- To review the critical control points in apoptosis.
- To highlight the role of the BCL-2 protein family in regulating cell death.
- To discuss the molecular mechanisms and therapeutic implications of apoptosis regulation.
Main Methods:
- Literature review of findings from multiple laboratories.
- Analysis of molecular interactions and conformational changes within BCL-2 family proteins.
- Synthesis of current knowledge on apoptosis regulation.
Main Results:
- The BCL-2 family proteins are central regulators of the intrinsic apoptotic pathway.
- Aberrant apoptosis underlies various human diseases.
- The BCL-2 oncogene's discovery highlighted its role in follicular lymphoma.
Conclusions:
- Apoptosis is an intricate process governed by BCL-2 family proteins.
- Understanding BCL-2 family interactions is key to developing therapies for apoptosis-related diseases.
- Tight regulation of molecular interactions within the BCL-2 family determines cell fate.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy
The Extrinsic Apoptotic Pathway
Negative Regulator Molecules
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and function at the cell...
The Cell Cycle Control System

